Steps taken after granting the Marketing Authorisation 
For procedures finalised after 01/11/04 please refer to module 8B. 
Scope 
Application 
number 
Type of 
modification1 
Notification/ 
Opinion 
issued on2 
Extension of shelf-life or retest period of the active substance 
Update of Summary of Product Characteristics and Package 
Leaflet 
Addition of new strength 
Change in or addition of manufacturing site(s) for part or all 
of the manufacturing process 
Extension of Indication and Addition of new strength 
Minor change in the manufacturing process of the active 
substance and Change in spec. of active subst./agent used in 
manuf. of active subst. – tightening 
Change in the specification of the finished product - 
tightening of specification limits 
Change in test procedure of finished product - other changes 
I/03 
II/04 
X/05 
I/06 
X/07 
IB/08 
IB/09 
IB/11 
I 
II 
X 
I 
X 
IB 
IB 
IB 
02.12.02 
24.07.03 
24.07.03 
07.08.03 
29.07.04 
13.01.04 
13.01.04 
21.07.04 
Commission 
Decision 
Issued/amen
ded on 
11.12.02 
07.11.03 
24.10.03 
22.09.03 
12.11.04 
- 
- 
- 
1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a 
minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor 
variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II 
application. 
T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 
of 7 November 1996.  
N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992. 
2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification 
date. The Commission Decision will be amended accordingly. 
1/1 
   EMEA 2004 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                            
 
